External Funding Opportunities
We invite you to peruse the following list of funding opportunities that may be of interest to injury prevention researchers. This information is abstracted for brevity; please refer to the sponsor’s website for complete information.
To add other opportunities to this list, please email us.
In addition, we often publicize funding opportunities via our mailing list. Please become a member to join our mailing list and receive updated information.
- Screening, Brief Intervention, and Referral to Treatment (Application Due Date: April 19, 2021)
- Provider’s Clinical Support System – Universities (Application Due Date: April 20, 2021)
- Rigorous Evaluation of Policies for their Impacts on the Primary Prevention of Multiple Forms of Violence (Application Due Date: April 05, 2021)
- Research Grants for Preventing Violence and Violence-Related Injury (Application Due Date: March 22, 2021)
- Certified Community Behavioral Health Clinic Expansion Grants (Application Due Date: March 1, 2021)
- Grants to Prevent Prescription Drug/Opioid Overdose-Related Deaths (Application Due Date: March 1, 2021)
- Music and Health: Understanding And Developing Music Medicine (R01 Clinical Trial Optional) (Expiration Date: February 06, 2023)
- Music and Health: Understanding And Developing Music Medicine (R21 Clinical Trial Optional) (Expiration Date: February 17, 2023)
- Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R34 Clinical Trial Optional) (Application Due Dates: February 19, 2021, June 17, 2021, October 19, 2021, February 17, 2022, June, 17, 2022, October 18, 2022, February 17, 2023, June 19, 2023, October 17, 2023)
- Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional) (Application Due Dates: February 19, 2021, June 17, 2021, October 19, 2021, February 17, 2022, June, 17, 2022, October 18, 2022, February 17, 2023, June 19, 2023, October 17, 2023)
- Multi-Site Studies for System-Level Implementation of Substance Use Prevention and Treatment Services (R01 Clinical Trial Optional) (Application Due Dates: July 19, 2021; November 15, 2021; July 19, 2022; November 15, 2022; July 19, 2023; November 15, 2023 – each letter of intent due 30 days prior)
- Multi-Site Studies for System-Level Implementation of Substance Use Prevention and Treatment Services (R34 Clinical Trial Optional)
- Notice of Intent to Publish a Funding Opportunity Announcement for HEAL Initiative: Optimizing Multi-Component Service Delivery Interventions for People with Opioid Use Disorder, Co-Occurring Conditions, and/or Suicide Risk (R01 Clinical Trials Optional)
- State Occupational Safety and Health Surveillance Program (U60)
- NIOSH Exploratory/Developmental Grant Program (R21)
- Forecast: Rural Communities Opioid Response Program – Implementation
- Forecast: Rural Communities Opioid Response Program – Psychostimulant Support
- Lizette Peterson-Homer Injury Prevention Grant
- NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional)
- Notice of Intent to Publish a Funding Opportunity Announcement for Service-Ready Tools for Identification, Prevention, and Treatment of Individuals at Risk for Suicide (R34 Clinical Trial Optional)
- Notice of Special Interest (NOSI) in Research on Risk and Prevention of Black Youth Suicide
- Notice of Special Interest (NOSI): Research on Co-morbid Substance Use, Substance Use Disorders, and Other Psychiatric Disorders
- NIDA Research Education Program for Clinical Researchers and Clinicians (R25 Clinical Trial Not Allowed)
- Alcohol and Other Substance Use Research Education Programs for Health Professionals (R25 Clinical Trial Not Allowed)
- Substance Use/Substance Use Disorder Dissertation Research Award (R36 – Clinical Trials Optional)
- Advancing Research on SUD through Computational Neuroscience
- Cannabis, Prescription Opioid, or Prescription Benzodiazepine Drug Use Among Older Adults
- Long-Term Effects of Disasters on Health Care Systems Serving Health Disparity Populations (R01- Clinical Trial Optional)
- Clinical and Translational Science Award (CTSA) Program: Collaborative Innovation Award (U01 Clinical Trial Optional)
- Clinical and Translational Science Award (CTSA) Program: Exploratory Collaborative Innovation Awards (R21 Clinical Trial Optional)
- Innovation at Work
- Practice-Based Research for Implementing Scalable Evidence-Based Prevention Interventions in Primary Care Settings (R01 Clinical Trial Optional)
- Practice-Based Research for Implementing Scalable Evidence-Based Prevention Interventions in Primary Care Settings (R34 Clinical Trial Required)
- Integrative Research on Polysubstance Abuse and Disorder (R61/R33 Clinical Trial Optional)
- Gun Violence Prevention & Justice Reform Grants
- HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Required)
- HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Not Allowed)
- HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 – Clinical Trial Required)
- HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 – Clinical Trial Not Allowed)
- Pilot Studies to Detect and Prevent Suicide Behavior, Ideation and Self-Harm in Youth in Contact with the Juvenile Justice System (R34 Clinical Trial Required)
- Accelerating the Pace of Drug Abuse Research Using Existing Data (R01 Clinical Trial Optional)
- HEAL Initiative: America’s Startups and Small Businesses Build Technologies to Stop the Opioid Crisis (R43/R44 – Clinical Trial Optional)
- HEAL Initiative: America’s Startups and Small Businesses Build Technologies to Stop the Opioid Crisis (R41/R42 – Clinical Trial Optional)
- High-Priority Areas for Research Leveraging EHR and Large-Scale Data (R01 Clinical Trial Not Allowed)
- AHRQ Health Services Research Demonstration and Dissemination Grants (R18)
- AHRQ Small Research Grant Program (R03)
- AHRQ Health Services Research Projects (R01)
- Alcohol and Other Substance Use Research Education Programs for Health Professionals (R25 Clinical Trial Not Allowed)
- Alcohol and Other Drug Interactions: Unintentional Injuries and Overdoses: Epidemiology and Prevention (R21 – Clinical Trial Optional)
- Alcohol and Other Drug Interactions: Unintentional Injuries and Overdoses: Epidemiology and Prevention (R03 – Clinical Trial Optional)
- Alcohol and Other Drug Interactions: Unintentional Injuries and Overdoses: Epidemiology and Prevention (R01 – Clinical Trial Optional)
- Mechanism for Time-Sensitive Drug Abuse Research (R21 Clinical Trial Optional)
- Occupational Safety and Health Research (R01)